The yellow zone in asthma treatment: is it a gray zone?

Area of Science:

• Pulmonary Medicine
• Asthma Management
• Clinical Practice Guidelines

Background:

• National Institutes of Health (NIH) guidelines recommend written action plans for home management of asthma exacerbations (yellow zone).
• Current criteria for identifying the asthma "yellow zone" are often ambiguous, causing confusion for patients and healthcare providers.
• There is a lack of evidence-based recommendations for yellow zone treatment strategies within existing asthma guidelines.

Purpose of the Study:

• To review literature on preventing and minimizing asthma exacerbations.
• To identify areas for improvement in current asthma management guidelines.
• To target problems in the definition and management of asthma "yellow zone" exacerbations.

Main Methods:

• Conducted literature searches in PubMed and Cochrane Review.
• Utilized keywords such as "asthma exacerbation," "self-management plans," "inhaled corticosteroids," and "acute management of asthma exacerbations."
• Selected articles relevant to yellow zone intervention strategies.

Main Results:

• NIH guidelines suggest written action plans for yellow zone exacerbations but lack clear yellow zone definitions.
• Physicians and patients find current yellow zone criteria confusing.
• Limited evidence exists on the efficacy of pharmacological interventions for yellow zone exacerbations, with only a mention of doubling inhaled corticosteroid doses.

Conclusions:

• A clearer, more patient-friendly definition of the asthma "yellow zone" is essential for effective clinical practice.
• Improved yellow zone definitions will enable better prescription of interventions for managing exacerbations.
• Translating NIH guidelines into practice requires addressing the ambiguity in yellow zone identification and treatment recommendations.